Patent · US Active

Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins

US9265791B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

Baxalta Incorporated · CH

Inventors

Peter Turecek · Klosterneuburg, AT
Susanne Vejda · Wien, AT

Key dates

Filing date	Jan 21, 2014
Grant date	Feb 23, 2016
Priority date	—
Expiry date	Feb 1, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Aspects of the invention include methods for treating or preventing a thromboembolic disease in a subject. In practicing methods according to certain embodiments, an amount of a low molecular weight heparin (LMWH) and a synergistically effective combination of two or more gastrointestinal epithelial barrier permeation enhancers is orally administered to a subject in a manner sufficient to treat the thromboembolic disease in the subject. Compositions and kits for practicing methods of the invention are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.